Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer

被引：0
|
作者：
Kurozumi, Sasagu [1 ]
Green, Andrew R. [1 ]
Ellis, Ian O. [1 ]
Rakha, Emad A. [1 ]
Fujii, Takaaki [2 ]
Shirabe, Ken [2 ]
Heery, David [3 ]
Zwart, Wilbert [4 ]
Oesterreich, Steffi [5 ,6 ]
Johnston, Simon J. [1 ]
机构：
[1] Univ Nottingham, Nottingham Breast Canc Res Ctr, Nottingham, England
[2] Gunma Univ, Dept Gen Surg Sci, Grad Sch Med, Gunma, Japan
[3] Univ Nottingham, Sch Pharm, Gene Regulat Lab, Nottingham, England
[4] Netherlands Canc Inst, Amsterdam, Netherlands
[5] UPMC Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA USA
[6] Magee Women Res Inst, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P1-18-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-18-06
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Heritable Variation of ERBB2 and Breast Cancer Risk
    Breyer, Joan P.
    Sanders, Melinda E.
    Airey, David C.
    Cai, Qiuyin
    Yaspan, Brian L.
    Schuyler, Peggy A.
    Dai, Qi
    Boulos, Fouad
    Olivares, Maria G.
    Bradley, Kevin M.
    Gao, Yu-Tang
    Page, David L.
    Dupont, William D.
    Zheng, Wei
    Smith, Jeffrey R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (04) : 1252 - 1258
  • [32] Future options in the treatment of ErbB2 (HER2)-positive breast cancer
    Fumoleau, Pierre
    EJC SUPPLEMENTS, 2008, 6 (05): : 25 - 31
  • [33] COMPLETE - Study the ErbB2 (HER2) - positive Breast cancer.
    Arnheim, Katharina
    Aktas, Bahriye
    ONKOLOGIE, 2010, 33 (04):
  • [34] ERBB2 kinase mutations in lung-cancer tumours
    Senior, K
    LANCET ONCOLOGY, 2004, 5 (11): : 647 - 647
  • [35] Discovery of somatic ERBB2 mutations in human gallbladder cancer
    Iyer, P.
    Gardi, N.
    Ranjan, M.
    Chandrani, P.
    Upadhyay, P.
    Ramadwar, M. R.
    Shrikhande, S. V.
    Dutt, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S55 - S55
  • [36] MET and ERBB2 Are Coexpressed in ERBB2+ Breast Cancer and Contribute to Innate Resistance
    Paulson, Amanda K.
    Linklater, Erik S.
    Berghuis, Bree D.
    App, Colleen A.
    Oostendorp, Leon D.
    Paulson, Jayne E.
    Pettinga, Jane E.
    Melnik, Marianne K.
    Woude, George F. Vande
    Graveel, Carrie R.
    MOLECULAR CANCER RESEARCH, 2013, 11 (09) : 1112 - 1121
  • [37] ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas
    Deniziaut, Gabrielle
    Tille, Jean Christophe
    Bidard, Francois-Clement
    Vacher, Sophie
    Schnitzler, Anne
    Chemlali, Walid
    Tremoulet, Laurence
    Fuhrmann, Laetitia
    Cottu, Paul
    Rouzier, Roman
    Bieche, Ivan
    Vincent-Salomon, Anne
    ONCOTARGET, 2016, 7 (45) : 73337 - 73346
  • [38] Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors
    Ronellenfitsch, Michael W.
    Harter, Patrick N.
    Kirchner, Martina
    Heining, Christoph
    Hutter, Barbara
    Gieldon, Laura
    Schittenhelm, Jens
    Schuhmann, Martin U.
    Tatagiba, Marcos
    Marquardt, Gerhard
    Wagner, Marlies
    Endris, Volker
    Brandts, Christian H.
    Mautner, Victor-Felix
    Schroeck, Evelin
    Weichert, Wilko
    Brors, Benedikt
    von Deimling, Andreas
    Mittelbronn, Michel
    Steinbach, Joachim P.
    Reuss, David E.
    Glimm, Hanno
    Stenzinger, Albrecht
    Froehling, Stefan
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05): : 2488 - 2495
  • [39] Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
    Michael Marotta
    Taku Onodera
    Jeffrey Johnson
    G. Thomas Budd
    Takaaki Watanabe
    Xiaojiang Cui
    Armando E. Giuliano
    Atsushi Niida
    Hisashi Tanaka
    Scientific Reports, 7
  • [40] Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer
    Marx, Corina
    Yau, Christina
    Banwait, Surita
    Zhou, Yamei
    Scott, Gary K.
    Hann, Byron
    Park, John W.
    Benz, Christopher C.
    MOLECULAR PHARMACOLOGY, 2007, 71 (06) : 1525 - 1534
12345